Physician

Adnan Pervez, MD

According to 2025 Medicare claims, Adnan Pervez, MD (NPI: 1013017748) practices pulmonary disease in the Raleigh-Cary, NC market, with the plurality of this provider's patient population coming from Wake, NC. This provider's primary affiliated billing organization is REX HOSPITAL INC (NPI: 1861777468; TIN: 561509260) and primary practice location at 27607-0112. Pervez is affiliated with the CHESS Genesis, LLC (ACO ID: D0237), participating under the REACH model.

Pervez's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 768 traditional Medicare patients, billed 1,347 HCPCS/CPT codes, and received $81,704 in Medicare payments. The top billing code was 95811 (Sleep study in sleep lab with continuous airway pressure (6 years or older)). Part D data shows 1,166 prescription claims across 251 beneficiaries totaling $462,623 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 1,907 claims. Open Payments data shows 7 records totaling $362. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $128,627 to $81,704. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $172,983 to $462,623. For DME billing, reported payments rose steadily, from $86,779 to $105,864.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	622	1,810	$128,627
2016	673	1,758	$127,551
2017	695	1,693	$124,964
2018	795	1,690	$124,359
2019	907	2,075	$142,087
2020	839	1,720	$118,150
2021	829	1,565	$117,155
2022	777	1,383	$109,223
2023	785	1,493	$87,773
2024	768	1,347	$81,704

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	187	1,134	$172,983
2016	191	1,043	$188,968
2017	244	1,255	$301,326
2018	313	1,604	$511,143
2019	354	2,069	$789,022
2020	351	1,852	$857,516
2021	284	1,179	$404,513
2022	270	1,149	$508,795
2023	258	999	$452,624
2024	251	1,166	$462,623

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	278	1,094	$110,437
2016	418	1,328	$103,936
2017	460	1,263	$88,103
2018	555	1,721	$126,148
2019	927	2,526	$155,976
2020	902	2,599	$159,044
2021	791	2,228	$126,357
2022	653	1,920	$131,666
2023	660	1,761	$120,475
2024	793	1,907	$95,730

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95811	Sleep study in sleep lab with continuous airway pressure (6 years or older)	158	164	$87
95810	Sleep study in sleep lab (6 years or older)	110	112	$78
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	165	205	$64
95806	Sleep study including heart rate, breathing, airflow, and effort	107	110	$32
94729	Test to examine how well the lungs exchange gases	109	109	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	198	6,990	$144,068
Prolastin C	Alpha-1-Proteinase Inhibitor	13	336	$121,183
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	68	2,640	$40,265
Breo Ellipta	Fluticasone/Vilanterol	89	2,970	$38,837
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	30	1,200	$18,465

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A7031	Face mask interface, replacement for full face mask, each	N	83	191	$18,269
A7030	Full face mask used with positive airway pressure device, each	N	85	184	$16,982
A4604	Tubing with integrated heating element for use with positive airway pressure device	N	111	233	$9,104
E0601	Continuous positive airway pressure (cpap) device	Y	43	268	$8,635
E0471	Respiratory assist device, bi-level pressure capability, with back-up rate feature, used with noninvasive interface, e.g., nasal or facial mask (intermittent assist device with continuous positive airway pressure device)	Y	N/R	30	$6,273

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	7	$362	Inspire Medical Systems, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adnan Pervez, MD?

Tedicare shows public-source Medicare data for Adnan Pervez, MD (NPI 1013017748), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adnan Pervez, MD have ACO affiliation data?

Adnan Pervez, MD is shown with ACO affiliation data for CHESS Genesis, LLC (REACH, ACO ID D0237).

What billing organization is linked to Adnan Pervez, MD?

Adnan Pervez, MD is linked to REX HOSPITAL INC (billing NPI 1861777468) in the available physician profile data.

Does Adnan Pervez, MD have Open Payments data?

Adnan Pervez, MD has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.